rs779953279
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PM4_Supporting
The NM_000335.5(SCN5A):c.3190_3192delGAG(p.Glu1064del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,609,408 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000335.5 conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.3190_3192delGAG | p.Glu1064del | conservative_inframe_deletion | Exon 17 of 28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.3190_3192delGAG | p.Glu1064del | conservative_inframe_deletion | Exon 17 of 28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.3190_3192delGAG | p.Glu1064del | conservative_inframe_deletion | Exon 17 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.3190_3192delGAG | p.Glu1064del | conservative_inframe_deletion | Exon 17 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248268Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134650
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1457216Hom.: 0 AF XY: 0.0000221 AC XY: 16AN XY: 723858
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74344
ClinVar
Submissions by phenotype
not provided Uncertain:3
This variant, c.3190_3192del, results in the deletion of 1 amino acid(s) of the SCN5A protein (p.Glu1064del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs779953279, gnomAD 0.008%). This variant has been observed in individual(s) with Brugada syndrome (PMID: 30193851). ClinVar contains an entry for this variant (Variation ID: 201565). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The c.3190_3192delGAG variant has not been published as a mutation or as a benign polymorphism to our knowledge. This variant results in deletion of Glutamic acid 1064 and does not cause a shift in reading frame. However, other non-frameshift mutations in the SCN5A gene have been reported in association with SCN5A-related disorders. Furthermore, the c.3190_3192delGAG variant was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. -
- -
Cardiovascular phenotype Uncertain:1
The c.3190_3192delGAG variant (also known as p.E1064del) is located in coding exon 16 of the SCN5A gene. This variant results from an in-frame GAG deletion at nucleotide positions 3190 to 3192. This results in the in-frame deletion of a glutamic acid residue at codon 1064, located in the DII/DIII interdomain linker region. This alteration has been detected in a Brugada syndrome cohort; however, clinical details were limited (Berthome P et al. Heart Rhythm, 2019 Feb;16:260-267). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al., PLoS ONE 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at